▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2252 by analyst upside · 2026-06-27
UTHR
United Therapeutics Corporation
Healthcare · Market Cap $23B · P/E 20.1x
ANALYST PRICE TARGET
+22.6%
implied upside to consensus target
Current Price $542.66
Consensus Target $665.23
Bull Target $750.0
Bear Target $516.0
Analysts Covering 13
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
8
Hold
4
Sell
0
52-Week Low $272.12
52-Week High $609.35
YTD Return +9.2%
FUNDAMENTALS
Market Cap $23B
P/E Ratio (TTM) 20.1x
Forward P/E 17.1x
EPS (TTM) $27.01
PEG Ratio 2.25
Dividend Yield N/A
Revenue (TTM) $3.2B
Profit Margin 40.6%
52-WEEK RANGE
52-Week Low $272.12
52-Week High $609.35
Current Price $542.66
Bear Target $516.0
Bull Target $750.0
● Now $542.66 ● Target $665.23
TRADING DATA
Avg Volume 536K
YTD Return +9.2%
Analyst Count 13
Consensus Buy
Upside to Target +22.6%
Last Updated 2026-06-27

ANALYST SUMMARY

United Therapeutics Corporation (UTHR) is currently trading at $542.66 with a Wall Street consensus price target of $665.23, implying potential upside of 22.6% over the next 12 months. 13 analysts currently cover UTHR, with a consensus rating of Buy — 69% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $750.0, while the most cautious has a target of $516.0.

UTHR operates in the Healthcare sector with a market capitalisation of $23B. The stock is up 9.2% year-to-date and is currently trading near the upper end of its 52-week range of $272.12 – $609.35.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

LH +14.2%
Labcorp Holdings Inc.
$22B · P/E 23.6x · Buy
STE +19.1%
STERIS plc
$21B · P/E 27.2x · Buy
PHG +23.8%
Koninklijke Philips N.V.
$26B · P/E 24.0x · Buy
DGX +6.5%
Quest Diagnostics Incorporated
$23B · P/E 22.8x · Buy
DXCM +21.5%
DexCom, Inc.
$27B · P/E 30.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for UTHR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital — Reiterated
Outperform → Outperform 2026-05-07 Building track record
Wells Fargo ↑ Upgrade
Equal-Weight → Overweight 2026-05-07 Building track record
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-04-10 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-03-31 31% win rate (48 calls)
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-03-31 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-03-31 Building track record
TD Cowen — Reiterated
Buy → Buy 2026-03-30 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-03-23 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →